Note: Mouseover a species abbreviation on the product page to display the fullname.
How can we help you?
![Flow Cytometry: CD4 Antibody (CE9.1 (Clenoliximab)) - Chimeric [NBP2-52681] - Flow-cytometry using the anti-CD4 research biosimilar antibody Clenoliximab (NBP2-52681) Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Clenoliximab (panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD4-Antibody-CE9-1-Clenoliximab-Chimeric-Flow-Cytometry-NBP2-52681-img0001.jpg "Flow Cytometry: CD4 Antibody (CE9.1 (Clenoliximab)) - Chimeric [NBP2-52681] - Flow-cytometry using the anti-CD4 research biosimilar antibody Clenoliximab (NBP2-52681) Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Clenoliximab (panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Western Blot: CD4 Antibody (CE9.1 (Clenoliximab)) - Chimeric [NBP2-52681] - Human thyroid tumour samples were resolved on a 15% SDS PAGE gel and blots probed with the human IgG4-chimeric version of CE9.1 (NBP2-75910) at 1.5 ug/ml before detection using an anti-human IgG4 secondary antibody. Protein was detected by chemiluminescence. The expected unmodified running size for CD4 is 51kDa (arrowhead). Here some non-specific bands can also be seen. NBP2-75910 successfully detected CD4 in human thyroid tissue samples.](http://images.novusbio.com/fullsize/CD4-Antibody-CE9-1-Clenoliximab-Chimeric-Western-Blot-NBP2-52681-img0004.jpg)
![Immunohistochemistry: CD4 Antibody (CE9.1 (Clenoliximab)) - Chimeric [NBP2-52681] - Anti-CD4 staining of formaldehyde fixed paraffin embedded guinea pig skin tissue, at 40x magnification. The human IgG4-chimeric version of CE9.1 (Clenoliximab) (NBP2-75910) was used to stain samples at a concentration of 3 ug/ml.](http://images.novusbio.com/fullsize/CD4-Antibody-CE9-1-Clenoliximab-Chimeric-Immunohistochemistry-NBP2-52681-img0003.jpg)
![Immunohistochemistry: CD4 Antibody (CE9.1 (Clenoliximab)) [NBP2-75910] - Anti-CD4 staining of formaldehyde fixed paraffin embedded guinea pig skin tissue, at 40x magnification. The human IgG4-chimeric version of CE9.1 (Clenoliximab) (NBP2-75910) was used to stain samples at a concentration of 3 ug/ml.](http://images.novusbio.com/fullsize/CD4-Antibody-CE9-1-Clenoliximab-Immunohistochemistry-NBP2-75910-img0002.jpg "Immunohistochemistry: CD4 Antibody (CE9.1 (Clenoliximab)) [NBP2-75910] - Anti-CD4 staining of formaldehyde fixed paraffin embedded guinea pig skin tissue, at 40x magnification. The human IgG4-chimeric version of CE9.1 (Clenoliximab) (NBP2-75910) was used to stain samples at a concentration of 3 ug/ml.")
![Western Blot: CD4 Antibody (CE9.1 (Clenoliximab)) [NBP2-75910] - Human thyroid tumour samples were resolved on a 15% SDS PAGE gel and blots probed with the human IgG4-chimeric version of CE9.1 (NBP2-75910) at 1.5 ug/ml before detection using an anti-human IgG4 secondary antibody. Protein was detected by chemiluminescence. The expected unmodified running size for CD4 is 51kDa (arrowhead). Here some non-specific bands can also be seen. NBP2-75910 successfully detected CD4 in human thyroid tissue samples.](http://images.novusbio.com/fullsize/CD4-Antibody-CE9-1-Clenoliximab-Western-Blot-NBP2-75910-img0003.jpg)